Newron Pharmaceuticals S.p.A. (SWX: NWRN)
Switzerland
· Delayed Price · Currency is CHF 8.81
-0.14 (-1.56%)
Jan 3, 2025, 5:31 PM CET
Newron Pharmaceuticals Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 7.9 | 6.34 | 13.42 | 25.02 | 13.21 | 22.05 | Upgrade
|
| Short-Term Investments | 4.29 | 6.26 | 9.35 | 9.58 | 18.04 | 17.11 | Upgrade
|
| Cash & Short-Term Investments | 12.19 | 12.6 | 22.77 | 34.59 | 31.25 | 39.16 | Upgrade
|
| Cash Growth | -28.89% | -44.68% | -34.17% | 10.70% | -20.21% | -10.69% | Upgrade
|
| Accounts Receivable | 2.01 | 2.02 | 1.94 | 1.31 | 6.62 | 1.75 | Upgrade
|
| Other Receivables | 3.44 | 3.16 | 3.03 | 2.74 | - | 3.26 | Upgrade
|
| Receivables | 5.44 | 5.18 | 4.97 | 4.05 | 6.62 | 5.01 | Upgrade
|
| Prepaid Expenses | 2.45 | 1.87 | 0.75 | 0.78 | - | 1.32 | Upgrade
|
| Total Current Assets | 20.08 | 19.65 | 28.49 | 39.43 | 37.87 | 45.49 | Upgrade
|
| Property, Plant & Equipment | 0.34 | 0.41 | 0.53 | 0.58 | 0.73 | 0.25 | Upgrade
|
| Other Intangible Assets | - | - | - | 0 | 0.01 | 0.02 | Upgrade
|
| Other Long-Term Assets | 4.52 | 5.81 | 8.18 | 10.48 | 12.58 | 14.53 | Upgrade
|
| Total Assets | 24.94 | 25.87 | 37.2 | 50.49 | 51.2 | 60.29 | Upgrade
|
| Accounts Payable | 2.87 | 2.02 | 1.91 | 1.5 | 1.27 | 2.41 | Upgrade
|
| Accrued Expenses | 1.74 | 3.49 | 2.17 | 1.1 | 3.28 | 2.4 | Upgrade
|
| Current Portion of Long-Term Debt | - | 22.28 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.18 | 0.18 | 0.17 | 0.15 | 0.15 | 0.06 | Upgrade
|
| Other Current Liabilities | 0.59 | 0.97 | 0.79 | 0.9 | 2.19 | 0.73 | Upgrade
|
| Total Current Liabilities | 5.38 | 28.93 | 5.04 | 3.65 | 6.89 | 5.6 | Upgrade
|
| Long-Term Debt | 48.53 | 25.75 | 45.17 | 42.54 | 25.67 | 16.75 | Upgrade
|
| Long-Term Leases | 0.14 | 0.21 | 0.33 | 0.39 | 0.52 | 0.08 | Upgrade
|
| Other Long-Term Liabilities | 1.3 | 0.47 | 0.22 | 0.21 | 0.18 | 0.44 | Upgrade
|
| Total Liabilities | 55.77 | 55.77 | 51.23 | 47.38 | 33.95 | 23.49 | Upgrade
|
| Common Stock | 3.81 | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | Upgrade
|
| Additional Paid-In Capital | - | - | - | 5.1 | 26.1 | 46.31 | Upgrade
|
| Retained Earnings | -14.72 | -21.4 | -22.81 | -20.12 | -26.16 | -25.34 | Upgrade
|
| Comprehensive Income & Other | -19.92 | -12.08 | 5.21 | 14.55 | 13.74 | 12.26 | Upgrade
|
| Shareholders' Equity | -30.83 | -29.91 | -14.03 | 3.11 | 17.25 | 36.8 | Upgrade
|
| Total Liabilities & Equity | 24.94 | 25.87 | 37.2 | 50.49 | 51.2 | 60.29 | Upgrade
|
| Total Debt | 48.85 | 48.42 | 45.66 | 43.08 | 26.35 | 16.89 | Upgrade
|
| Net Cash (Debt) | -36.66 | -35.82 | -22.89 | -8.49 | 4.91 | 22.28 | Upgrade
|
| Net Cash Growth | - | - | - | - | -77.98% | -48.88% | Upgrade
|
| Net Cash Per Share | -2.01 | -2.01 | -1.28 | -0.48 | 0.27 | 1.25 | Upgrade
|
| Filing Date Shares Outstanding | 19.06 | 17.85 | 17.85 | 17.85 | 17.85 | 17.85 | Upgrade
|
| Total Common Shares Outstanding | 19.05 | 17.85 | 17.85 | 17.85 | 17.85 | 17.85 | Upgrade
|
| Working Capital | 14.7 | -9.27 | 23.45 | 35.77 | 30.98 | 39.9 | Upgrade
|
| Book Value Per Share | -1.62 | -1.68 | -0.79 | 0.17 | 0.97 | 2.06 | Upgrade
|
| Tangible Book Value | -30.83 | -29.91 | -14.03 | 3.11 | 17.24 | 36.78 | Upgrade
|
| Tangible Book Value Per Share | -1.62 | -1.68 | -0.79 | 0.17 | 0.97 | 2.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.